Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 7,580 shares at $476.14 ($3.9M) on 2026-09-30, disclosed to the SEC on 2026-10-01.
Scheduled sale ($3.9M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $476.14 | 161 | $77K | 2.0% |
| 2 | $477.43 | 749 | $358K | 9.1% |
| 3 | $478.47 | 650 | $311K | 7.9% |
| 4 | $479.67 | 359 | $172K | 4.4% |
| 5 | $480.79 | 601 | $289K | 7.4% |
| 6 | $482.36 | 160 |
| $77K |
| 2.0% |
| 7 | $487.79 | 80 | $39K | 1.0% |
| 8 | $495.32 | 40 | $20K | 0.5% |
| 9 | $511.37 | 40 | $20K | 0.5% |
| 10 | $514.90 | 80 | $41K | 1.0% |
| 11 | $517.16 | 80 | $41K | 1.1% |
| 12 | $523.36 | 80 | $42K | 1.1% |
| 13 | $524.62 | 80 | $42K | 1.1% |
| 14 | $526.09 | 80 | $42K | 1.1% |
| 15 | $531.11 | 160 | $85K | 2.2% |
| 16 | $536.52 | 160 | $86K | 2.2% |
| 17 | $537.67 | 200 | $108K | 2.7% |
| 18 | $538.65 | 40 | $22K | 0.5% |
| 19 | $540.78 | 480 | $260K | 6.6% |
| 20 | $541.76 | 580 | $314K | 8.0% |
| 21 | $543.25 | 600 | $326K | 8.3% |
| 22 | $544.05 | 840 | $457K | 11.6% |
| 23 | $545.13 | 920 | $502K | 12.8% |
| 24 | $546.23 | 360 | $197K | 5.0% |
| Total | $517.97 avg | 7,580 | $3.9M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |